Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kriyana P. Reddy"'
Autor:
Kriyana P. Reddy, Lauren A. Eberly, Rim Halaby, Howard Julien, Sameed Ahmed M. Khatana, Elias J. Dayoub, Megan Coylewright, Mohamad Alkhouli, Paul N. Fiorilli, Taisei J. Kobayashi, David M. Goldberg, Pasquale Santangeli, Howard C. Herrmann, Jay Giri, Peter W. Groeneveld, Alexander C. Fanaroff, Ashwin S. Nathan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 5 (2023)
Background Inequitable access to high‐technology therapeutics may perpetuate inequities in care. We examined the characteristics of US hospitals that did and did not establish left atrial appendage occlusion (LAAO) programs, the patient populations
Externí odkaz:
https://doaj.org/article/56ca36818ded4a0794c8de00ca149ba5
Publikováno v:
Cardiology in the Young. :1-3
Introduction: Racial and ethnic disparities in resource use among children with CHD remain understudied. We sought to evaluate associations between race, ethnicity, and resource utilisation in children with CHD. Materials and methods: Annual data fro
Autor:
Kriyana P. Reddy, Rebecca T. Brown
Publikováno v:
International journal of geriatric psychiatryREFERENCES. 37(9)
Publikováno v:
Circulation: Cardiovascular Interventions. 15
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, with the number of procedures and sites offering the procedure steadily rising over the past decade in the United States. Despite this, growth into cer
Autor:
Ashwin S. Nathan, Kriyana P. Reddy, Lin Yang, Lauren A. Eberly, Elias J. Dayoub, Sameed A. M. Khatana, Howard M. Julien, Nimesh D. Desai, Wilson Y. Szeto, Howard C. Herrmann, Taisei J. Kobayashi, Paul Fiorilli, Wayne B. Batchelor, Roxana Mehran, Mohamad Adnan Alkhouli, Jay Giri, Peter W. Groeneveld, Alexander C. Fanaroff
Publikováno v:
JAMA Cardiology. 8:120
ImportanceRacial and ethnic minority and socioeconomically disadvantaged patients have been underrepresented in randomized clinical trials. Efforts have focused on enhancing inclusion of minority groups at sites participating at clinical trials; howe